Sandy, UT (PRWEB) January 08, 2015
Co-Diagnostics, Inc. announced today that on Monday, December 15, the company received official certificates for ISO 13485, the design and manufacture of medical devices (registration no. 10013216 MP23) and ISO 9001, the fundamental requirements of a Quality Management System (registration no. 10013216 QM08).
The International Organization of Standards, or ISO, is a non-government entity comprised of academic and industry professionals which certifies that companies are compliant with industry-standard best practices in their production and operations.
These ISO certifications are granted to DNA Logix Inc., a wholly-owned subsidiary of Co-Diagnostics, Inc., and they verify that the Quality Management System of DNA Logix fulfills ISO standards for design, development, testing, and manufacturing of tuberculosis tests and their components.
Co-Diagnostics CEO Dwight Egan noted, “We are pleased to receive our official ISO certification and the international credibility that comes along with it. Having been granted this certification for the production of our tuberculosis tests, we look forward to expanding its scope to all existing and future products to achieve our goal of spreading our unique, life-saving technology across the globe.”
Co-Diagnostics, Inc., a molecular diagnostics company, is a Utah corporation based in Sandy, Utah that develops, manufactures and markets fully integrated DNA test systems. The company’s intellectual property is based on mathematical principles that create algorithms in a unique DNA-based diagnostics system that is superior in cost and speed of development to all other such systems, both in the US and abroad.